Heart failure is a condition where the heart cannot pump enough blood to meet the body’s needs. The main symptoms are:
- General fatigue or weakness
- Shortness of breath
- Swelling in the legs and ankles
Heart failure can change a person’s life. Symptoms, medicines and hospital stays can make life difficult. This lowers the quality of a person’s life. Heart failure can get worse over time. Without effective treatment, most people with heart failure die within five years of being diagnosed.1
A new clinical research study is enrolling patients with heart failure. The study is called Barostim™ HOPE4HF™ (Health Outcomes Prospective Evaluation for Heart Failure with EF ≤ 35%). The Barostim HOPE4HF study will test the safety and efficacy of Barostim neo™ in people with heart failure.
Sixty patients will be randomized into two groups of thirty patients to either receive Barostim neo™ or receive optimal medical management. The Barostim HOPE4HF study will determine whether Barostim neo™ can:
- Reduce heart failure symptoms
- Improve heart function
- Help patients live longer
- Improve quality of life
- Reduce the number of hospital stays due to heart failure
If you would like to learn more about this study, a doctor involved in the study will speak with you about possible risks and benefits.
To find out about enrolling in the Barostim HOPE4HF study, please go to Enrolling in the Study.
See if YOU qualify
1. Douglas S. Lee, Philmon Gona, et al. Pathogenesis and Risk Factors to Heart Failure with Preserved or Reduced Ejection Fraction. Circulation. 2009; 119; 3070-3077